Cyclic compound having pyrimidinylalkylthio group

Details Cyclic compound having pyrimidinylalkylthio group Cyclic compound having pyrimidinylalkylthio group

2011-03-15

2011-03-15

Rao, Deepak (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S252140, C514S252180, C514S275000, C544S122000, C544S295000, C544S316000, C544S318000, C544S331000, C544S332000

Reexamination Certificate

active

07906511

ABSTRACT:
The present invention has its object to study synthesis of novel cyclic compounds having a pyrimidinylalkylthio group and to find pharmacological actions of the compounds. According to the present invention, a compound represented by the formula (1) or a salt thereof is provided.In the formula, the ring X represents:R1and R2independently represent a hydrogen atom, an alkyl group, an aryl group, an aromatic heterocyclic group or the like; R3represents a hydrogen atom, a halogen atom, a hydroxy group, an alkoxy group, an aryloxy group, an alkyl group, an aryl group, an amino group, an alkylamino group or the like; A1represents a sulfur atom or the like; and A2represents an alkylene group.

REFERENCES:
patent: 2003/0073845 (2003-04-01), Barta et al.
patent: 2003/0171404 (2003-09-01), Barta et al.
patent: WO 97/30035 (1997-08-01), None
patent: WO 98/35958 (1998-08-01), None
patent: WO 98/50356 (1998-11-01), None
patent: WO 00/27819 (2000-05-01), None
patent: WO 01/55114 (2001-08-01), None
patent: WO 02/066470 (2002-08-01), None
patent: WO 03/007930 (2003-01-01), None
patent: WO 03/007954 (2003-01-01), None
patent: WO 03/016306 (2003-02-01), None
patent: WO 2004/005279 (2004-01-01), None
patent: WO 2004/078723 (2004-09-01), None
patent: WO 2005/085201 (2005-09-01), None
Fabbro et al., Protein kinases as targets for anticancer agents: from inhibitors to useful drugs, Pharmacology & Therapeutics, 93, pp. 79-98, 2002.
Traxler, Protein tyrosine kinase inhibitors in cancer treatment, Exp. Opin. Ther. Patents, 7(6), pp. 571-588, 1997.
Simone, Oncology: Introduction, 20th Edition, vol. 1, pp. 1004-1010, 1996.
Cressey et al., Medline Abstract (BMC Cancer, vol. 5, p. 128) Oct. 2005.
Yano et al., Medline Abstract (Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, vol. 6, Issue 3, pp. 957-965) Mar. 2000.
Molecular Medicine, vol. 35, special issue, “Molecular Mechanism of Symptoms and Pathologic Conditions,” Nakayama Shoten, 73-74 (1998).
Protein, Nucleic Acid, Enzyme, extra number, “The Most Advanced Development of New Drugs,” Kyoritsu Shuppan, 1182-1187 (2000).

Affiliated with

Also associated with

Rating

Cyclic compound having pyrimidinylalkylthio group does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclic compound having pyrimidinylalkylthio group, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic compound having pyrimidinylalkylthio group will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2729105